{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T17:06:51Z","timestamp":1767805611453,"version":"3.49.0"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T00:00:00Z","timestamp":1757462400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.ejps.2025.107271","type":"journal-article","created":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T15:49:28Z","timestamp":1757605768000},"page":"107271","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Time shift in ciclosporin metabolism downregulation by inflammation in allogeneic hematopoietic cell transplantation: A time-dependent transduction modelling PK-PD approach"],"prefix":"10.1016","volume":"214","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5650-852X","authenticated-orcid":false,"given":"David","family":"Malno\u00eb","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4932-2169","authenticated-orcid":false,"given":"Tony","family":"Marchand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4483-0957","authenticated-orcid":false,"given":"Pascal","family":"Le Corre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2025.107271_bib0001","doi-asserted-by":"crossref","first-page":"2630","DOI":"10.1093\/jac\/dkad293","article-title":"Can we predict the influence of inflammation on voriconazole exposure? An overview","volume":"78","author":"Boglione-Kerrien","year":"2023","journal-title":"J. Antimicrob. Chemother"},{"key":"10.1016\/j.ejps.2025.107271_bib0002","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1111\/j.1365-2125.2012.04260.x","article-title":"Population PK\/PD analysis of metformin using the signal transduction model","volume":"74","author":"Chae","year":"2012","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.ejps.2025.107271_bib0003","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/clpt.1994.82","article-title":"Acute-phase response, interleukin-6, and alteration of cyclosporine pharmacokinetics","volume":"55","author":"Chen","year":"1994","journal-title":"Clin. Pharmacol. Ther"},{"key":"10.1016\/j.ejps.2025.107271_bib0004","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1097\/FTD.0b013e3181d5881f","article-title":"Prediction of intravenous cyclosporine area under the concentration-time curve after allogeneic stem cell transplantation","volume":"32","author":"Duncan","year":"2010","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.ejps.2025.107271_bib0005","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1345\/aph.10380","article-title":"Factors influencing cyclosporine blood concentration\u2014Dose ratio","volume":"36","author":"Garc\u00eda-S\u00e1iz","year":"2002","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.ejps.2025.107271_bib0006","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1002\/cpt.1496","article-title":"Modulation of CYP450 activities in patients with type 2 diabetes","volume":"106","author":"Gravel","year":"2019","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.ejps.2025.107271_bib0007","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1111\/bcp.15916","article-title":"Individualized treatment with voriconazole in the Chinese population: inflammation level as a novel marker for dose optimization","volume":"90","author":"Hao","year":"2024","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.ejps.2025.107271_bib0008","doi-asserted-by":"crossref","first-page":"2930","DOI":"10.1002\/jps.23590","article-title":"Moving from basic toward systems pharmacodynamic models","volume":"102","author":"Jusko","year":"2013","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.ejps.2025.107271_bib0009","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1177\/1060028015577798","article-title":"Population pharmacokinetics of cyclosporine in hematopoietic stem cell transplant patients: consideration of genetic polymorphisms","volume":"49","author":"Kim","year":"2015","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.ejps.2025.107271_bib0010","doi-asserted-by":"crossref","DOI":"10.1111\/cts.13887","article-title":"Inflammation altered correlation between CYP2C19 genotype and CYP2C19 activity in patients receiving voriconazole","volume":"17","author":"Klomp","year":"2024","journal-title":"Clin Transl Sci"},{"key":"10.1016\/j.ejps.2025.107271_bib0011","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1002\/cpt.2698","article-title":"Impact of inflammation on midazolam metabolism in severe COVID-19 patients","volume":"112","author":"Le Carpentier","year":"2022","journal-title":"Clin. Pharmacol. Ther"},{"key":"10.1016\/j.ejps.2025.107271_bib0012","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1455721","article-title":"Influence of C-reactive protein on the pharmacokinetics of voriconazole in relation to the CYP2C19 genotype: a population pharmacokinetics analysis","volume":"15","author":"Ling","year":"2024","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.ejps.2025.107271_bib0013","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1615\/CritRevBiomedEng.v40.i4.50","article-title":"Pharmacokinetic\/pharmacodynamic modeling in inflammation","volume":"40","author":"Lon","year":"2012","journal-title":"Crit Rev Biomed Eng"},{"key":"10.1016\/j.ejps.2025.107271_bib0014","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1248\/bpb.b22-00097","article-title":"Impact of inflammation on intra-individual variation in trough voriconazole concentration in patients with hematological malignancies","volume":"45","author":"Maeda","year":"2022","journal-title":"Biol. Pharm. Bull"},{"key":"10.1016\/j.ejps.2025.107271_bib0015","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1067\/mcp.2001.118244","article-title":"Pharmacodynamic modeling of time-dependent transduction systems","volume":"70","author":"Mager","year":"2001","journal-title":"Clin. Pharmacol. Ther"},{"key":"10.1016\/j.ejps.2025.107271_bib0016","first-page":"dkaf063","article-title":"Drug\u2013drug interaction between letermovir and ciclosporin in allogeneic haematopoietic cell transplantation recipients","author":"Malno\u00eb","year":"2025","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.ejps.2025.107271_bib0017","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/jcph.6141","article-title":"Inflammation decreases ciclosporin metabolism in allogeneic hematopoietic stem cell transplantation recipients","volume":"65","author":"Malno\u00eb","year":"2025","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.ejps.2025.107271_bib0018","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1093\/clinids\/21.1.114","article-title":"A prospective study of daily measurement of C-reactive protein in serum of adults with neutropenia","volume":"21","author":"Manian","year":"1995","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ejps.2025.107271_bib0019","doi-asserted-by":"crossref","first-page":"784","DOI":"10.2174\/18755453MTE05NDYa1","article-title":"Absorption, metabolism, distribution, and excretion of Letermovir","volume":"22","author":"Menzel","year":"2021","journal-title":"Curr. Drug Metab"},{"key":"10.1016\/j.ejps.2025.107271_bib0020","doi-asserted-by":"crossref","unstructured":"Morgan, E.T., 2024. Shining a light on inflammation as a critical modulator of drug metabolism. Drug metabolism and disposition: the biological fate of chemicals 52, 1039\u20131047. 10.1124\/dmd.124.001844.","DOI":"10.1124\/dmd.124.001844"},{"key":"10.1016\/j.ejps.2025.107271_bib0021","doi-asserted-by":"crossref","first-page":"e157","DOI":"10.1016\/S2352-3026(19)30256-X","article-title":"Prophylaxis and management of graft versus host disease after stem-cell transplantation for haematological malignancies: updated consensus recommendations of the European Society for Blood and Marrow Transplantation","volume":"7","author":"Penack","year":"2020","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.ejps.2025.107271_bib0022","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1111\/j.1365-2125.2009.03534.x","article-title":"Pharmacokinetics, metabolism and bioavailability of the triazole antifungal agent voriconazole in relation to CYP2C19 genotype","volume":"68","author":"Scholz","year":"2009","journal-title":"Brit J Clin. Pharma"},{"key":"10.1016\/j.ejps.2025.107271_bib0023","doi-asserted-by":"crossref","DOI":"10.7759\/cureus.53421","article-title":"Tacrolimus concentration\/dose ratio: A tool for guiding Tacrolimus dosage post-renal transplantation","author":"Shenoy","year":"2024","journal-title":"Cureus"},{"key":"10.1016\/j.ejps.2025.107271_bib0024","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1086\/421997","article-title":"Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis","volume":"39","author":"Simon","year":"2004","journal-title":"Clin. infect. dis. : off. publ. Infect. Dis. Soc. Am."},{"key":"10.1016\/j.ejps.2025.107271_bib0025","doi-asserted-by":"crossref","first-page":"754","DOI":"10.3389\/fimmu.2018.00754","article-title":"Role of C-reactive protein at sites of inflammation and infection","volume":"9","author":"Sproston","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.ejps.2025.107271_bib0026","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2020.107627","article-title":"Inflammation is a major regulator of drug metabolizing enzymes and transporters: consequences for the personalization of drug treatment","volume":"215","author":"Stanke-Labesque","year":"2020","journal-title":"Pharmacol. Ther"},{"key":"10.1016\/j.ejps.2025.107271_bib0027","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1002\/jcph.2024","article-title":"Predictive value of C-reactive protein and albumin for temporal within-individual pharmacokinetic variability of voriconazole in pediatric patients undergoing hematopoietic cell transplantation","volume":"62","author":"Takahashi","year":"2022","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.ejps.2025.107271_bib0028","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1097\/01.CCM.0000281517.97507.6E","article-title":"Effects of hypothermia on drug disposition, metabolism, and response: A focus of hypothermia-mediated alterations on the cytochrome P450 enzyme system","volume":"35","author":"Tortorici","year":"2007","journal-title":"Crit Care Med"},{"key":"10.1016\/j.ejps.2025.107271_bib0029","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2023.106750","article-title":"Voriconazole exposure is influenced by inflammation: A population pharmacokinetic model","volume":"61","author":"van den Born","year":"2023","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.ejps.2025.107271_bib0030","doi-asserted-by":"crossref","first-page":"7098","DOI":"10.1128\/AAC.03820-14","article-title":"Inflammation is associated with voriconazole trough concentrations","volume":"58","author":"van Wanrooy","year":"2014","journal-title":"Antimicrob. Agents Chemother"},{"key":"10.1016\/j.ejps.2025.107271_bib0031","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1124\/dmd.108.023630","article-title":"Regulation of drug transporter expression in Human hepatocytes exposed to the proinflammatory cytokines Tumor necrosis Factor-\u03b1 or Interleukin-6","volume":"37","author":"Vee","year":"2009","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ejps.2025.107271_bib0032","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/jac\/dkw349","article-title":"Voriconazole metabolism is influenced by severe inflammation: a prospective study","volume":"72","author":"Veringa","year":"2017","journal-title":"J. Antimicrob. Chemother"}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098725002696?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098725002696?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T15:45:42Z","timestamp":1767800742000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098725002696"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":32,"alternative-id":["S0928098725002696"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2025.107271","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Time shift in ciclosporin metabolism downregulation by inflammation in allogeneic hematopoietic cell transplantation: A time-dependent transduction modelling PK-PD approach","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2025.107271","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"107271"}}